Teva Changed Its Tune on OxyContin Patent, Purdue Claims
Purdue Pharma LP fired off a complaint in New York federal court last week alleging Teva Pharmaceuticals USA Inc. will infringe its patent by marketing a generic version of the popular...To view the full article, register now.
Already a subscriber? Click here to view full article